SMS - Study of Somatic Mutations Using Genome Sequencing
NCT ID: NCT06851052
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
600 participants
OBSERVATIONAL
2016-10-01
2028-07-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sample Collection Study to Assess Prevalence of Gene Mutations: Establishing Population Norms
NCT05079737
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
NCT03829176
Integrative Sequencing In Germline and Hereditary Tumours
NCT03857594
Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy
NCT03043209
Investigating the Role of Genetics in Disease Predisposition
NCT06584994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls
Healthy adults with capacity to consent these may be patient's relatives either recruited by the research nurse or clinician, or recruited via posters put up around the hospital requesting volunteers.
sample collection
Samples could include blood, skin biopsy, urine, plucked hair.
Seeking consent
Patients
Adults with capacity to consent who have been highlighted by research nurse or clinician as potentially having genetic damage caused by environmental factors, such as UV light or tobacco smoke, or other factors, such as disease history or treatments, for example radiotherapy.
sample collection
Samples could include blood, skin biopsy, urine, plucked hair.
Seeking consent
Sample Collection: Surgical
Excess surgical tissue (diseased tissue or tissue being removed for a clinical reason).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sample collection
Samples could include blood, skin biopsy, urine, plucked hair.
Seeking consent
Sample Collection: Surgical
Excess surgical tissue (diseased tissue or tissue being removed for a clinical reason).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients: Adults with capacity to consent who have been highlighted by research nurse or clinician as potentially having genetic damage caused by environmental factors, such as UV light or tobacco smoke, or other factors, such as disease history or treatments, for example radiotherapy.
Exclusion Criteria
* Children.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cambridge University Hospitals NHS Foundation Trust
OTHER
Hull University Teaching Hospitals NHS Trust
OTHER_GOV
The Wellcome Sanger Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phil Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
Wellcome Sanger Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wellcome Sanger Institute
Cambridge, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
182435
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.